Screening for Gaucher Disease and Acid Sphingomyelinase Deficiency
ConditionGaucher Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorChung-Hsing Wang
About this trial
High-risk screening for Gaucher disease and Acid Sphingomyelinase Deficiency in patients with splenomegaly and/or thrombocytopenia in Taiwan
Eligibility criteria
Qualifiers
Clinical diagnosis of splenomegaly
Clinical diagnosis of thrombocytopenia
Disqualifiers
Clinical diagnosis of gaucher disease
Clinical diagnosis of acid sphingomyelinase
Clinical diagnosis of malignant tumors
Trial design
Treatments tested in this trial
- Not listed
Trial groups
50 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov